United States · Funded startup

Who invested in Organogenesis

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$20Mraised across 1 round since 2017, from 1 source

Latest round
Debt, $20MMay 2017
Investors
1
See who backed them

The rounds

  1. May 2017

Founders and team

From Organogenesis's own website: 5 on the team.

  • Brian GrowChief Commercial Officer
  • David C. FranciscoChief Financial Officer
  • Lori FreedmanChief Administrative and Legal Officer
  • Patrick BilboChief Operating Officer
  • Robert CavorsiChief Business Officer

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Organogenesis

Who invested in Organogenesis?

Organogenesis's investors include Eastward Capital Partners.

How much has Organogenesis raised?

Organogenesis has raised $20M across 1 round since 2017.

When did Organogenesis last raise?

Organogenesis's most recent round was a Debt of $20M in May 2017.

What was Organogenesis's biggest round?

Its most recent round, $20M in May 2017, is also its largest on record.

Who backed Organogenesis first?

Organogenesis's first round on record, in May 2017, was backed by Eastward Capital Partners.

What stage is Organogenesis at?

Organogenesis's latest named round is a Debt, in May 2017.

Where is Organogenesis based?

Organogenesis is based in the United States.

Companies like Organogenesis

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.